10722007

Source:http://linkedlifedata.com/resource/pubmed/id/10722007

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007137, umls-concept:C0008976, umls-concept:C0021083, umls-concept:C0205195, umls-concept:C0205390, umls-concept:C0460004
pubmed:issue	3
pubmed:dateCreated	2000-3-30
pubmed:abstractText	To test the efficacy of a natural cytokine mixture (IRX-2), cyclophosphamide, indomethacin, and zinc to induce immune regression of squamous cell carcinoma (SCC) of the head and neck (H&N) prior to conventional therapy and to characterize the responses.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8603209
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/IRX 2, http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin, http://linkedlifedata.com/resource/pubmed/chemical/Zinc
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0886-4470
pubmed:author	pubmed-author:BarreraJ LJL, pubmed-author:HaddenJ WJW, pubmed-author:MenesesAA, pubmed-author:VerasteguiEE, pubmed-author:ZinserJJ, pubmed-author:de la GarzaJJ
pubmed:issnType	Print
pubmed:volume	126
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	345-51
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10722007-Adult, pubmed-meshheading:10722007-Aged, pubmed-meshheading:10722007-Aged, 80 and over, pubmed-meshheading:10722007-Carcinoma, Squamous Cell, pubmed-meshheading:10722007-Combined Modality Therapy, pubmed-meshheading:10722007-Cyclophosphamide, pubmed-meshheading:10722007-Cytokines, pubmed-meshheading:10722007-Disease-Free Survival, pubmed-meshheading:10722007-Drug Combinations, pubmed-meshheading:10722007-Female, pubmed-meshheading:10722007-Head and Neck Neoplasms, pubmed-meshheading:10722007-Humans, pubmed-meshheading:10722007-Immunotherapy, pubmed-meshheading:10722007-Indomethacin, pubmed-meshheading:10722007-Lymphatic Metastasis, pubmed-meshheading:10722007-Lymphocyte Activation, pubmed-meshheading:10722007-Male, pubmed-meshheading:10722007-Middle Aged, pubmed-meshheading:10722007-Neoadjuvant Therapy, pubmed-meshheading:10722007-Neoplasm Staging, pubmed-meshheading:10722007-Zinc
pubmed:year	2000
pubmed:articleTitle	Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial.
pubmed:affiliation	Department of Surgery, National Institute of Cancerology, Mexico City, Mexico.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II